Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2016 Filed Jun 13, 2016 22:25 UTC |
HILL CHARLES HExecutive Vice President
|
OtherPhantom Stock Units SSP · Derivative | 11,328 | $35.31 | $399,991.68 |
DisclosureSEC source: 0001225208-16-034955 · doc4.xml · derivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,987 Underlying: Common Stock · 11,328 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: This transaction constitutes an intra-plan transfer involving the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2016 Filed Jun 3, 2016 00:18 UTC |
BOURLA ALBERTGroup President
|
GrantPhantom Stock Units SSP · Derivative | 21 | $34.70 | $728.70 |
DisclosureSEC source: 0001225208-16-034507 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,586 Underlying: Common Stock · 21 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2016 Filed Jun 3, 2016 00:18 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 4 | $34.70 | $138.80 |
DisclosureSEC source: 0001225208-16-034508 · doc4.xml · derivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,757 Underlying: Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2016 Filed Jun 3, 2016 00:18 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 226 | $34.70 | $7,842.20 |
DisclosureSEC source: 0001225208-16-034509 · doc4.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,248 Underlying: Common Stock · 226 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2016 Filed Jun 3, 2016 00:18 UTC |
YOUNG JOHN DGroup President
|
GrantPhantom Stock Units SSP · Derivative | 11 | $34.70 | $381.70 |
DisclosureSEC source: 0001225208-16-034510 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,606 Underlying: Common Stock · 11 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 26, 2016 Filed May 27, 2016 15:03 UTC |
DAMELIO FRANK AExecutive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $24.43 | $0.00 |
DisclosureSEC source: 0001225208-16-034087 · doc4.xml · derivative · entry 7 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2017-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options are fully exercisable. Read SEC document |
| May 26, 2016 Filed May 27, 2016 15:03 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 71,938 | $34.49 | $2,481,141.62 |
DisclosureSEC source: 0001225208-16-034087 · doc4.xml · nonDerivative · entry 5 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,994 Read SEC document |
| May 26, 2016 Filed May 27, 2016 15:03 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 20,999 | $34.50 | $724,465.50 |
DisclosureSEC source: 0001225208-16-034087 · doc4.xml · nonDerivative · entry 4 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 444,932 Read SEC document |
| May 26, 2016 Filed May 27, 2016 15:03 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 4,663 | $34.48 | $160,780.24 |
DisclosureSEC source: 0001225208-16-034087 · doc4.xml · nonDerivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465,931 Read SEC document |
| May 26, 2016 Filed May 27, 2016 15:03 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 2,400 | $34.47 | $82,728.00 |
DisclosureSEC source: 0001225208-16-034087 · doc4.xml · nonDerivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,594 Read SEC document |
| May 26, 2016 Filed May 27, 2016 15:03 UTC |
DAMELIO FRANK AExecutive Vice President
|
Exercise / conversionCommon Stock | 100,000 | $24.43 | $2,443,000.00 |
DisclosureSEC source: 0001225208-16-034087 · doc4.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 472,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2016 Filed May 26, 2016 14:07 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 86,000 | $0.00 Strike: $25.87 | $0.00 |
DisclosureSEC source: 0001225208-16-034012 · doc4.xml · derivative · entry 8 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 86,000 shares Expires 2017-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2016 Filed May 26, 2016 14:07 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
SaleCommon Stock | 30,958 | $33.96 | $1,051,333.68 |
DisclosureSEC source: 0001225208-16-034012 · doc4.xml · nonDerivative · entry 6 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,663 Read SEC document |
| May 24, 2016 Filed May 26, 2016 14:07 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
SaleCommon Stock | 19,642 | $33.97 | $667,238.74 |
DisclosureSEC source: 0001225208-16-034012 · doc4.xml · nonDerivative · entry 5 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,621 Read SEC document |
| May 24, 2016 Filed May 26, 2016 14:07 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
SaleCommon Stock | 18,231 | $33.99 | $619,671.69 |
DisclosureSEC source: 0001225208-16-034012 · doc4.xml · nonDerivative · entry 4 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,263 Read SEC document |
| May 24, 2016 Filed May 26, 2016 14:07 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
SaleCommon Stock | 16,669 | $33.95 | $565,912.55 |
DisclosureSEC source: 0001225208-16-034012 · doc4.xml · nonDerivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,494 Read SEC document |
| May 24, 2016 Filed May 26, 2016 14:07 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
SaleCommon Stock | 500 | $33.98 | $16,990.00 |
DisclosureSEC source: 0001225208-16-034012 · doc4.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,163 Read SEC document |
| May 24, 2016 Filed May 26, 2016 14:07 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
Exercise / conversionCommon Stock | 86,000 | $25.87 | $2,224,820.00 |
DisclosureSEC source: 0001225208-16-034012 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2016 Filed May 16, 2016 20:42 UTC |
BOURLA ALBERTGroup President
|
GrantPhantom Stock Units SSP · Derivative | 21 | $33.19 | $696.99 |
DisclosureSEC source: 0001225208-16-033367 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,570 Underlying: Common Stock · 21 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 13, 2016 Filed May 16, 2016 20:42 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 4 | $33.19 | $132.76 |
DisclosureSEC source: 0001225208-16-033368 · doc4.xml · derivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,755 Underlying: Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 13, 2016 Filed May 16, 2016 20:42 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 236 | $33.19 | $7,832.84 |
DisclosureSEC source: 0001225208-16-033369 · doc4.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,069 Underlying: Common Stock · 236 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 13, 2016 Filed May 16, 2016 20:42 UTC |
YOUNG JOHN DGroup President
|
GrantPhantom Stock Units SSP · Derivative | 11 | $33.19 | $365.09 |
DisclosureSEC source: 0001225208-16-033370 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,598 Underlying: Common Stock · 11 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 11, 2016 Filed May 12, 2016 12:21 UTC |
OLSON LAURIE JExecutive Vice President
|
SaleCommon Stock | 4,700 | $33.50 | $157,450.00 |
DisclosureSEC source: 0001225208-16-033182 · doc4.xml · nonDerivative · entry 1 OLSON LAURIE J · CIK 0001553231 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,659 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 192,000 | $0.00 Strike: $24.43 | $0.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · derivative · entry 30 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 192,000 shares Expires 2017-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options are fully exercisable. Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 35,102 | $33.83 | $1,187,500.66 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 28 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,994 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 17,334 | $33.58 | $582,075.72 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 27 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,096 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 15,900 | $33.69 | $535,671.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 26 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,430 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 14,500 | $33.50 | $485,750.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 25 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 441,330 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 13,611 | $33.59 | $457,193.49 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 24 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 455,830 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 12,766 | $33.57 | $428,554.62 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 23 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,441 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 11,620 | $33.67 | $391,245.40 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 22 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,207 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 10,789 | $33.60 | $362,510.40 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 21 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,827 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 9,100 | $33.61 | $305,851.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 20 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 504,616 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 8,300 | $33.52 | $278,216.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 19 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 513,716 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 7,300 | $33.56 | $244,988.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 18 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 522,016 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 6,400 | $33.76 | $216,064.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 17 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 529,316 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 4,998 | $33.79 | $168,882.42 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 16 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535,716 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 4,700 | $33.77 | $158,719.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 15 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,714 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 3,500 | $33.55 | $117,425.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 14 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,414 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 2,880 | $33.66 | $96,940.80 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 13 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 548,914 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 2,300 | $33.68 | $77,464.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 12 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 551,794 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 2,000 | $33.82 | $67,640.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 11 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 554,094 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 2,000 | $33.84 | $67,680.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 10 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556,094 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 1,800 | $33.54 | $60,372.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 9 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558,094 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 1,800 | $33.78 | $60,804.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 8 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 559,894 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 1,600 | $33.65 | $53,840.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 7 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561,694 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 800 | $33.49 | $26,792.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 6 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 563,294 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 600 | $33.86 | $20,316.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 5 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564,094 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 100 | $33.51 | $3,351.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 4 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564,694 Read SEC document |
| May 10, 2016 Filed May 11, 2016 22:04 UTC |
DAMELIO FRANK AExecutive Vice President
|
SaleCommon Stock | 100 | $33.62 | $3,362.00 |
DisclosureSEC source: 0001225208-16-033172 · doc4.xml · nonDerivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564,794 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.